Leadership & Expertise

Senior Regulatory Expertise Across Precision Medicine, Diagnostics & Drug Development:

Blue Tulip Solutions brings together regulatory sciences, biomarker strategy, IVD/CDx development and executive advisory to address complex development and regulatory decisions across the life sciences ecosystem.

Blue Tulip Solutions combines the expertise of Haydar Celik, PhD, with a carefully selected network of strategic partners to provide comprehensive guidance in FDA regulatory science, precision medicine, genomics, commercialization, and healthcare innovation. Together, we help organizations move confidently from scientific discovery to regulatory approval and commercial success.

Haydar Celik, PhD

Founder & Principal

Regulatory Affairs Executive | Former FDA Reviewer | Precision Medicine | IVD & CDx

  • Global Regulatory Strategy

  • Precision Medicine & Biomarker Strategy

  • IVD & Companion Diagnostic Development

  • Drug-Diagnostic Co-development

  • Digital HealthAI-Driven Healthcare Innovation

  • Product Development & Commercialization

  • Executive & Board-Level Strategic Advisory

Extended Advisory Network

Blue Tulip can engage experienced collaborators with complementary expertise when additional speacialized support is needed.

Strategic Impact→

Turn complex scientific and regulatory challenges into clear, actionable strategies. Blue Tulip Solutions helps life-science organizations reduce risk, strengthen product positioning, and accelerate the path from innovation to market. Our integrated approach connects science, regulation, and business to support confident decisions and sustainable growth.

Clear Regulatory Direction

Clear, practical regulatory strategies that align innovation, evidence, and business objectives from the earliest stages.

Reduced Development Risk

Early identification of regulatory, evidence, development and commercialization challenges to support more informed development decisions before they become costly delays.

Faster Path to Market

Focused strategies that support efficient development, stronger submissions, and timely market entry.

Stronger Strategic Positioning

Integrated scientific, regulatory, and business perspectives to shape compelling product, evidence generation, and market-access strategies that strengthen stakeholder alignment and investor confidence.

Stronger Strategic Positioning

Integrated scientific, regulatory, and business perspectives to shape compelling product, evidence generation, and market-access strategies that strengthen stakeholder alignment and investor confidence.

Faster Path to Market

Focused strategies that support efficient development, stronger submissions, and timely market entry.

Ready to Partner for Regulatory Strategies and Diagnostic Solutions?

Contact Blue Tulip to discuss your needs and discover how we can help you thrive.